Clinical Trials

Breast Neoplasms

NCT03818685 2024-02-12

BreastImmune03

95 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04844385 2024-02-09

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

124 enrolled

Esophageal Squamous Cell Carcinoma

NCT05042791 2024-02-09

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

362 enrolled

HER2-positive Metastatic Breast Cancer

NCT05980689 2024-02-07

Combination of AK104 and Neoadjuvant Chemoradiotherapy in pMMR/MSS Locally Advanced Rectal Cancer

33 enrolled

Locally Advanced Rectal Cancer

NCT05737563 2024-01-23

Escape

380 enrolled

Esophageal Squamous Cell Carcinoma

NCT06202014 2024-01-19

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

43 enrolled

Pancreatic Neoplasms

NCT06194981 2024-01-12

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

260 enrolled

Stomach Neoplasms

NCT05859477 2024-01-02

NIVOFGFR2

23 enrolled

Stomach Neoplasms

NCT04395989 2023-12-22

FUTURE-SUPER

139 enrolled

Triple Negative Breast Neoplasms

NCT06169202 2023-12-13

A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients

50 enrolled

Fruquintinib

NCT05578287 2023-12-07

DETECT

29 enrolled

Colorectal Neoplasms

NCT06156761 2023-12-05

Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer

Phase NA Unknown

24 enrolled

Breast Neoplasms

NCT03729687 2023-11-30

LARCT-US

280 enrolled

Rectal Neoplasms

NCT05262335 2023-11-28

ALTER-G-001

116 enrolled

Digestive System Neoplasms

NCT05512520 2023-11-18

EC-CRT-003

126 enrolled

Esophageal Squamous Cell Carcinoma

NCT04310176 2023-11-13

REVOLUTION

200 enrolled

Colorectal Neoplasms

NCT05307198 2023-10-10

RAIC

38 enrolled

Rectal Neoplasms

NCT00958737 2023-09-29

IDEA

2,000 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04259944 2023-09-28

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

140 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT05176964 2023-09-25

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

50 enrolled

Rectal Neoplasms

NCT06015100 2023-08-29

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Phase NA Unknown

Breast Neoplasms

NCT05415917 2023-08-22

Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy

75 enrolled

Pancreatic Neoplasms

NCT04262687 2023-08-18

POCHI

55 enrolled

Colorectal Cancer Metastatic

NCT04156698 2023-08-09

Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma

51 enrolled

Hypopharyngeal Neoplasms

NCT05974059 2023-08-03

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

20 enrolled

Locally Advanced Unresectable Gastric Adenocarcinoma

NCT04262635 2023-08-02

C-CLASSIC

80 enrolled

Colorectal Neoplasms

NCT03950154 2023-08-01

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

198 enrolled

Colorectal Neoplasms

NCT04250948 2023-08-01

Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer

108 enrolled

Stomach Neoplasms

NCT05965154 2023-07-28

Calizumab Combined With Bevacizumab and Capecitabine in the Treatment of Head and Neck Squamous Cell Carcinoma

22 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT04304352 2023-06-28

VEX

162 enrolled

Advanced Breast Cancer

NCT04072107 2023-06-18

EP-STAR

110 enrolled

Nasopharyngeal Carcinoma

NCT04083365 2023-05-31

PANDORA

100 enrolled

Rectal Neoplasms

NCT02288195 2023-05-12

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

663 enrolled

Rectal Neoplasms

NCT05833919 2023-04-27

Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients

122 enrolled

Breast Neoplasms

NCT05815303 2023-04-18

XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

92 enrolled

Rectal Neoplasms

NCT04522284 2023-03-29

PRECISE CURATE.AI Pilot Clinical Trial

Phase 1/2 Unknown

20 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Neoplasms

NCT01898104 2023-03-24

V-shoRT-R3

Phase 1/2 Unknown

152 enrolled

Colorectal Neoplasms

NCT04942899 2023-03-01

Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer

70 enrolled

Breast Neoplasms

NCT05747326 2023-02-28

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

30 enrolled

Breast Neoplasms

NCT05732493 2023-02-17

TORCH-C

120 enrolled

Locally Advanced Colon Cancer

NCT05549466 2023-02-08

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

84 enrolled

Nasopharyngeal Carcinoma

NCT05659290 2023-01-06

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Colorectal Neoplasms

NCT04001621 2022-12-08

Pyrotinib in Combination With Capecitabine in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer

100 enrolled

Breast Neoplasms

NCT05390476 2022-11-04

Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial

126 enrolled

Triple Negative Breast Neoplasms

NCT05411380 2022-11-04

Tucidinostat Combined With Metronomic Capecitabine and Endocrine Therapy for Advanced HR-positive, HER2-negative Breast Cancer After CDK4/6 Inhibitor.

73 enrolled

Breast Neoplasms

NCT05566743 2022-10-04

A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas

Pancreatic Neoplasms

NCT05545436 2022-09-22

Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer

34 enrolled

Locally Advanced Gastric Cancer

NCT04782804 2022-08-18

Adjuvant PD-1 Antibody in Combination With Capecitabine for Patients With ICC at High-Risk of Postoperative Recurrence

Phase 1/2 Unknown

30 enrolled

Cholangiocarcinoma

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

160 enrolled